It's Time to Get Into the TreeHouse

THS should begin to ... climb ... as acquisition is completed.

I Like Peloton to Keep Rolling in 2021, and Planet Fitness Might Be a Buy, Too

The former name is technically overbought but offers reasons to expect it to grow, while the latter should benefit from the Covid-19 vaccines.

Thor Industries Appears to Be on the Road to Higher Ground

The charts of the recreational vehicle maker seem to paint a developing positive picture.

Toss a Bitcoin Into the Mix, and Make a WISH

Despite a holiday drop off looming, we still have movement in bitcoin-related names, the Robinhood folks keep going, and check out ContextLogic's offering.

Psychedelic Industry Setting Up For an Even Bigger 2021

Dealmaking is going strong and looks set to continue as mental health becomes a key investment theme going forward.

I See a Door Opening to Get Into Fisker

A standard filing has led to an investing opportunity in this electric vehicle name.

How I'm Playing Astra-Zeneca on Vaccine and Acquisition News

I am staying away from this name for now, despite the Alexion acquisition and vaccine promise.

2 Potential Acquisition Targets as Biotech Deal Activity Picks Up

BioXcel Therapeutics and Avadel Pharmaceuticals would make good additions to the portfolios of larger drug companies.

This Market Party Is Not Over, Especially for SPACs

The weaker action this week is exactly what the market needs to keep running into the holidays.

Here's Where to Look Amid This Mad DASH on the Market

As the DoorDash IPO and Thursday's Airbnb offering get all the eyes, I'm watching special purpose acquisition companies, and here's why.